Basic and Diluted Net Income Per Share

6 Months Ended

Jun. 30, 2026

6.	Basic and Diluted Net Income Per Share

Basic earnings per share of Class A and Class B common stock is computed by dividing net income attributable to Guardian Pharmacy Services, Inc. by the weighted-average number of shares of Class A and Class B common stock outstanding during the period. The Class A and Class B common stock are identical in their rights and privileges, except that shares of Class B common stock are subject to transfer restrictions prior to their conversion into shares of Class A common stock. Therefore, the basic earnings per share for Class A and Class B common stock will be equal. Diluted earnings per share of Class A and Class B common stock is computed by dividing net income attributable to Guardian Pharmacy Services, Inc. by the weighted-average number of shares of Class A and Class B common stock outstanding, adjusted to give effect to potentially dilutive elements.

The following table sets forth the computation of net income attributable to the Company used to compute basic net income per share of Class A and Class B common stock for the three and six months ended June 30, 2025 and 2026.


(in thousands)	Three Months Ended June 30, 2025		Three Months Ended June 30, 2026		Six Months Ended June 30, 2025		Six Months Ended June 30, 2026

Numerator:
Net income	$	8,827	$	22,121	$	18,100	$	35,665
Less net income (loss) attributable to non-controlling interests		(203)		249		(378)		498

Net income attributable to Guardian Pharmacy Services, Inc.	$	9,030	$	21,872	$	18,478	$	35,167

The following table sets forth the computation of basic and diluted net income per share of Class A and Class B common stock (in thousands, except per share amounts):


	Three Months Ended June 30, 2026				Six Months Ended June 30, 2026
	Class A		Class B		Class A		Class B
Basic net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.	$	17,196	$	4,676	$	24,078	$	11,089
Denominator:
Weighted average number of shares of Class A and Class B common stock outstanding		49,787		13,539		43,357		19,967

Basic net income per share attributable to common stockholders	$	0.35	$	0.35	$	0.56	$	0.56

Diluted net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.	$	17,196	$	4,676	$	24,078	$	11,089
Denominator:
Number of shares used in basic computation		49,787		13,539		43,357		19,967
Dilutive Restricted Stock Units and Class A and B Common Stock		400		109		297		137
Weighted average shares of Class A and Class B common stock outstanding used to calculate diluted net income per share		50,187		13,648		43,654		20,104
Diluted net income per share attributable to common stockholders	$	0.34	$	0.34	$	0.55	$	0.55


	Three Months Ended June 30, 2025				Six Months Ended June 30, 2025
	Class A		Class B		Class A		Class B
Basic net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.	$	3,262	$	5,768	$	4,805	$	13,673
Denominator:
Weighted average number of shares of Class A and Class B common stock outstanding		22,412		39,634		16,134		45,910
Basic net income per share attributable to common stockholders	$	0.15	$	0.15	$	0.30	$	0.30
Diluted net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.	$	3,262	$	5,768	$	4,805	$	13,673
Denominator:
Number of shares used in basic computation		22,412		39,634		16,134		45,910
Dilutive Restricted Stock Units and Class A and B Common Stock		418		739		263		748
Weighted average shares of Class A and Class B common stock outstanding used to calculate diluted net income per share		22,830		40,373		16,397		46,658
Diluted net income per share attributable to common stockholders	$	0.14	$	0.14	$	0.29	$	0.29

There were no material anti-dilutive common share equivalents that were excluded in the computation of diluted net income per share during the three and six months ended June 30, 2025 and 2026.